Distinct roles for laminin globular domains in laminin α1 chain mediated rescue of murine laminin α2 chain deficiency

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Gawlik, Kinga I ^a   Åkerlund, Mikael ^a   Carmignac, Virginie ^a   Elamaa, Harri ^a,b   Durbeej, Madeleine ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROGLYCAN; LAMININ; LAMININ ALPHA1 GLOBULAR 4 DOMAIN; LAMININ ALPHA1 GLOBULAR 5 DOMAIN; LAMININ ALPHA2; UNCLASSIFIED DRUG; ALPHA INTEGRIN; ALPHA7 INTEGRIN; CREATINE KINASE; LAMININ A; LEUKOCYTE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIAPHRAGM; FEMALE; GENE FUNCTION; GENE INTERACTION; GENE OVEREXPRESSION; HEART MUSCLE; LIFESPAN; MALE; MOUSE; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; MUSCULAR DYSTROPHY WITH DYSMYELINATION NEUROPATHY; MYELINATION; NONHUMAN; PERIPHERAL NERVE; PROTEIN BINDING; SKELETAL MUSCLE; ANIMAL; BASEMENT MEMBRANE; BODY WEIGHT; FLUORESCENCE MICROSCOPY; GENETICS; IMMUNOBLOTTING; LOCOMOTION; METABOLISM; MYELIN SHEATH; PATHOLOGY; PERIPHERAL NERVOUS SYSTEM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TRANSGENIC MOUSE; TRANSMISSION ELECTRON MICROSCOPY;

MURINAE; MUS;

ANIMALS; ANTIGENS, CD; BASEMENT MEMBRANE; BODY WEIGHT; CREATINE KINASE; DYSTROGLYCANS; IMMUNOBLOTTING; INTEGRIN ALPHA CHAINS; LAMININ; LOCOMOTION; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MUSCLE, SKELETAL; MYELIN SHEATH; PERIPHERAL NERVOUS SYSTEM; PROTEIN STRUCTURE, TERTIARY;

EID: 77955394628     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011549     Document Type: Article

References (79)

1. Voit T, Tomé FS (2004) The congenital muscular dystrophies. In: Engel A, Franzini-Armstrong C, eds. Myology. New York: McGraw-Hill Inc. pp 1203-1238.
2. Miyagoe Y, Hanaoka K, Nonaka I, Hayasaka M, Nabeshima Y, et al. (1997) Laminin α2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy. FEBS Lett 415: 33-39.
3. Kuang W, Xu H, Vachon PH, Liu L, Loechel F, et al. (1998) Merosin-deficient congenital muscular dystrophy. J Clin Invest 102: 844-852.
4. Durbeej M, Campbell KP (2002) Muscular dystrophies involving the dystrophinglycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev 12: 349-361.
5. Miner JH (2008) Laminins and their roles in mammals. Microsc Res Tech 71: 349-356.
6. Sciandra F, Gawlik KI, Brancaccio A, Durbeej M (2007) Dystroglycan, a possible mediator for reducing congenital muscular dystrophy? Trends Biotechnol 25: 262-268.
7. Mayer U (2003) Integrins: redundant or important players in skeletal muscle? J Biol Chem 278: 14587-14590.
8. Barresi R, Campbell KP (2006) Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci 119: 199-207.
9. Côté PD, Moukhles H, Lindenbaum M, Carbonetto S (1999) Dystroglycan: from biosynthesis to pathogenesis of human disease. Nat Genet 23: 338-342.
10. Cohn RD, Henry MD, Michele DE, Barresi R, Saito F, et al. (2002) Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell 110: 639-648.
11. Satz JS, Barresi R, Durbeej M, Willer T, Turner A, et al. (2008) Brain and eye malformations resembling Walker-Warburg syndrome are recapitulated in mice by dystroglycan deletion in the epiblast. J Neurosci 28: 10567-10575.
12. Burkin DJ, Wallace GQ, Nicol KJ, Kaufman DJ, Kaufman SJ (2001) Enhanced expression of the a7b1 integrin reduces muscular dystrophy and restores viability in dystrophic mice. J Cell Biol 152: 1207-1218.
13. Allikian M, Hack AA, Mewborn S, Mayer U, McNally EM (2004) Genetic compensation for sarcoglycan loss by integrin α7b1 in muscle. J Cell Sci 117: 3821-3830.
14. Guo C, Willem M, Werner A, Raivich G, Emerson M, et al. (2006) Absence of α7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy. Hum Mol Genet 15: 989-998.
15. Han R, Kanagawa M, Yoshida-Moriguchi T, Rader EP, Ng RA, et al. (2009) Basal lamina strengthens cell membrane integrity via the laminin G domainbinding motif of α-dystroglycan. Proc Natl Acad Sci USA 106: 12573-12579.
16. Previtali SC, Nodari A, Taveggia C, Pardini C, Dina G, et al. (2003a) Expression of laminin receptors in schwann cell differentiation: evidence for distinct roles. J Neurosci 23: 5520-5530.
17. Nishiuchi R, Takagi J, Hayashi M, Ido H, Yagi Y, et al. (2006) Ligand-binding specificities of laminin-binding integrins: a comprehensive survey of lamininintegrin interactions using recombinant α3β1, α6β1, α7β1 and α6β4 integrins. Matrix Biol 25: 189-197.
18. Feltri ML, Graus Porta D, Previtali SC, Nodali A, Migliavacca B, et al. (2002) Conditional disruption of β1 integrin in Schwann cells impedes interactions with axons. J Cell Biol 156: 199-209.
19. Saito F, Moore SA, Barresi R, Henry MD, Messing A, et al. (2003) Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron 38: 747-758.
20. Nodari A, Previtali SC, Dati G, Occhi S, Court FA, et al. (2008) α6β4 integrin and dystroglycan cooperate to stabilize the myelin sheath. J Neurosci 28: 6714-6719.
21. Sorokin L, Sonnenberg A, Aumailley M, Timpl R, Ekblom P (1990) Recognition of the laminin E8 cell-binding site by an integrin possessing the α6 subunit is essential for epithelial polarization in developing kidney tubules. J Cell Biol 111: 1265-1273.
22. Lee EC, Lotz MM, Steele GD, Jr., Mercurio AM (1996) The integrin α6β4 is a laminin receptor. J Cell Biol 117: 671-678.
23. Talts JF, Andac Z, Gohring W, Brancaccio A, Timpl R (1999) Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, αdystroglycan and several extracellular matrix proteins. EMBO J 18: 863-870.
24. von der Mark H, Williams I, Wendler O, Sorokin L, von der Mark K, et al. (2002) Alternative splice variants of α7β1 integrin selectively recognize different laminin isoforms. J Biol Chem 277: 6012-6016.
25. Gawlik K, Miyagoe-Suzuki Y, Ekblom P, Takeda S, Durbeej M (2004) Laminin α1 chain reduces muscular dystrophy in laminin α2 chain deficient mice. Hum Mol Genet 13: 1775-1784.
26. Häger M, Gawlik K, Nyström A, Sasaki T, Durbeej M (2005) Laminin α1 chain corrects male infertility caused by absence of laminin α2 chain. Am J Pathol 167: 823-833.
27. Gawlik KI, Li J-Y, Petersen Å, Durbeej M (2006a) Laminin a1 chain improves laminin α2 chain deficient neuropathy. Hum Mol Genet 15: 2690-2700.
28. Gawlik KI, Durbeej M (2010) Transgenic overexpression of laminin α1 chain in laminin α2 chain deficient mice rescues the disease throughout the lifespan. Muscle Nerve in press.
29. Vachon PH, Xu H, Liu L, Loechel F, Hayashi Y, et al. (1997) Integrins (α7β1) in muscle function and survival. Disrupted expression in merosin deficient congenital muscular dystrophy. J Clin Invest 11: 1870-1881.
30. Moll J, Barzaghi P, Lin S, Bezakova G, Lochmuller H, et al. (2001) An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. Nature 413: 302-307.
31. Jimenez-Mallebrera C, Torelli S, Feng L, Kim J, Godfrey C, et al. (2009) A comparative study of α-dystroglycan glycosylation in dystroglycanopathies suggest that the hypoglycosylation of α-dystroglycan does not consistently correlate with clinical severity. Brain Pathol 19: 596-611.
32. Gawlik KI, Mayer U, Blomberg K, Sonnenberg A, Ekblom P, et al. (2006b) Laminin α1 chain mediated reduction of laminin α2 chain deficient muscular dystrophy involves integrin a7b1 and dystroglycan. FEBS Lett 580: 1759-1565.
33. Andac Z, Sasaki T, Mann K, Brancaccio A, Deutzmann R, et al. (1999) Analysis of heparin, α-dystroglycan and sulfatide binding to the G domain of the laminin a1 chain by site-directed mutagenesis. J Mol Biol 287: 253-264.
34. von der Mark H, Pöschl E, Lanig H, Sasaki T, Deutzmann R, et al. (2007) Distinct acidic clusters and hydrophobic residues in the alternative splice domains X1 and X2 of α7 integrins define specificity for laminin isoforms. J Mol Biol 371: 1188-1203.
35. Smirnov SP, McDearmon EL, Li S, Ervasti JM, Tryggvason K, et al. (2002) Contributions of the LG modules and furin processing to laminin-2 functions. J Biol Chem 277: 18928-18937.
36. Schéele S, Falk M, Franzén A, Ellin F, Ferletta M, et al. (2005) Laminin α1 globular domains 4-5 induce fetal development but are not vital for embryonic basement membrane assembly. Proc Natl Acad Sci USA 102: 1502-1506.
37. Cohn RD, Mayer U, Saher G, Herrmann R, van der Flier A, et al. (1999) Secondary reduction of α7B integrin in laminin α2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle. J Neurol Sci 163: 140-152.
38. Briguet A, Courdier-Fruh I, Foster M, Meier T, Magyar JP (2004) Histological parameters for quantitative assessment of muscular dystrophy in mdx mice. Neuromusc Dis 14: 675-682.
39. Patton BL, Miner JH, Chiu AY, Sanes JR (1997) Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice. J Cell Biol 139: 1507-1521.
40. Straub V, Rafael JA, Chamberlain JS, Campbell KP (1997) Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol 139: 375-385.
41. Mukasa T, Momoi T, Momoi MY (1999) Activation of caspase-3 apoptotic pathways in skeletal muscle fibers in laminin α2-deficient mice. Biochem Biophys Res Commun 260: 139-142.
42. Hayashi YK, Tezak Z, Momoi T, Nonaka I, Garcia CA, et al. (2001) Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy. Neuromuscul Disord 11: 350-359.
43. Ringelmann B, Roder C, Hallmann R, Maley M, Davies M, et al. (1999) Expression of laminin α1, α2, α4, and α5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice. Exp Cell Res 246: 165-182.
44. Qiao C, Li J, Zhu T, Draviam R, Watkins S, et al. (2005) Amelioration of laminin-α1, α2, α4, and α52-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin. Proc Natl Acad Sci USA 102: 11999-12004.
45. Shorer Z, Philpot J, Muntoni F, Sewry C, Dubowitz V (1995) Demyelinating peripheral nerve neuropathy in merosin-deficient congenital muscular dystrophy. J Child Neurol 10: 472-475.
46. 3K) mice. Glia 35: 101-110.
47. Quijano-Roy S, Renault F, Romero N, Guicheney P, Fardeau M, et al. (2004) EMG and nerve conduction studies in children with congenital muscular dystrophy. Muscle Nerve 29: 292-299.
48. Jaros E, Bradley WG (1979) Atypical axon-Schwann cell relationships in the common peroneal nerve of the dystrophic mouse: an ultrastructural study. Neuropathol Appl Neurobiol 5: 133-147.
49. Lindberg RL, Martini R, Baumgartner M, Erne B, Borg J, et al. (1999) Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria. J Clin Invest 103: 1127-1134.
50. Williams RW, Bastiani MJ, Lia B, Chalupa LM (1986) Growth cones, dying axons, and developmental fluctuations in the fiber population of the cat's optic nerve. J Comp Neurol 246: 32-69.
51. Sander S, Ouvrier RA, McLeod JG, Nicholson GA, Pollard JD (2000) Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsies. J Neurol Neurosurg Psych 68: 483-488.
52. Xu H, Christmas P, Wu X-R, Wewer UM, Engvall E (1994) Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc Natl Acad Sci USA 91: 5572-5576.
53. Yurchenco PD, Cheng YS, Campbell K, Li S (2004) Loss of basement membrane, receptor and cytoskeletal lattices in a laminin-deficient muscular dystrophy. J Cell Sci 117: 735-742.
54. Girgenrath M, Dominov JA, Kostek CA, Miller JB (2004) Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy. J Clin Invest 114: 1635-1639.
55. Girgenrath M, Beermann ML, Vishnudas VK, Homma S, Miller JB (2009) Pathology is alleviated by doxycycline in a laminin-α2-null model of congenital muscular dystrophy. Ann Neurol 65: 47-56.
56. Langenbach KJ, Rando TA (2002) Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells. Muscle Nerve 26: 644-653.
57. Rooney JE, Gurpur PB, Yablonka-Reuveni Z, Burkin DJ (2009) Laminin-111 restores regenerative capacity in a mouse model for α7 integrin congenital myopathy. Am J Pathol 174: 256-264.
58. Bentzinger CF, Barzaghi P, Lin S, Ruegg MA (2005) Overexpression of miniagrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-α2-deficient mice. FASEB J 19: 934-942.
59. Meinen S, Barzaghi P, Lin S, Lochmuller H, Ruegg MA (2007) Linker molecules between laminins and dystroglycan ameliorate laminin-α2-deficient muscular dystrophy at all disease stages. J Cell Biol 176: 979-993.
60. Previtali SC, Dina G, Nodali A, Fasolini M, Wrabetz L, et al. (2003b) Schwann cells synthesize α7beta;1 integrin which is dispensable for peripheral nerve development and myelination. Mol Cell Neurosci 23: 210-218.
61. Suzuki N, Ichikawa N, Kasai S, Yamada M, Nishi N, et al. (2003) Syndecan binding sites in the laminin α1 chain G domain. Biochemistry 43: 12625-12633.
62. Goutebroze L, Carnaud M, Denisenko N, Boutterin MC, Girault JA (2003) Syndecan-3 and syndecan-4 are enriched in Schwann cell perinodal processes. BMC Neurosci 18: 4:29.
63. Alexopoulou AN, Multhaupt HAB, Couchman JR (2007) Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol 29: 505-528.
64. Harrison D, Hussain DA, Combs AC, Ervasti JM, Yurchenco PD, et al. (2007) Crystal structure and cell surface anchorage sites of laminin α1LG4-5. J Biol Chem 282: 11573-11581.
65. Tisi D, Talts JF, Timpl R, Hohenester E (2000) Structure of the C-terminal laminin G-like domain pair of the laminin α2 chain harbouring binding sites for α-dystroglycan and heparin. EMBO J 19: 1432-1440.
66. Wizemann H, Garbe JH, Friedrich MV, Timpl R, Sasaki T, et al. (2003) Distinct requirements for heparin and α-dystroglycan binding revealed by structure-based mutagenesis of the laminin α2 LG4-LG5 domain pair. J Mol Biol 332: 635-642.
67. Mirsky R, Dubois C, Morgan L, Jessen KR (1990) 04 and A007-sulfatide antibodies bind to embryonic Schwann cells prior to the appearance of galactocerebroside; regulation of the antigen by axon-Schwann cell signals and cyclic AMP. Development 109: 105-116.
68. Li S, Liquari P, McKee KK, Harrison D, Patel R, et al. (2005) Laminin-sulfatide binding initiates basement membrane assembly and enables receptor signaling in Schwann cells and fibroblasts. J Cell Biol 169: 179-189.
69. Dupree JL, Coetzee T, Suzuki K, Popko B (1998) Myelin abnormalities in mice deficient in galactocerebroside and sulfatide. J Neurocytol 27: 649-659.
70. Honke K, Hirahara Y, Dupree J, Suzuki K, Popko B, et al. (2002) Paranodal junction formation and spermatogenesis require sulfoglycolipids. Proc Natl Acad Sci USA 99: 4227-4232.
71. Marcus J, Honigbaum S, Shroff S, Honke K, Rosenbluth J, et al. (2006) Sulfatide is essential for the maintenance of CNS myelin and axon structure. Glia 53: 372-381.
72. Ichikawa N, Iwabuchi K, Kurihara H, Ishii K, Kobayashi T, et al. (2009) Binding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowth. J Cell Sci 122: 289-299.
73. Sunada Y, Bernier SM, Utani A, Yamada Y, Campbell KP (1995) Identification of a novel mutant transcript of laminin a2 chain gene responsible for muscular dystrophy and dysmyelination in dy2J mice. Hum Mol Genet 4: 1055-1061.
74. (2J) mice is defective in its ability to form polymers. Curr Biol 9: 1327-1330.
75. Yang D, Bierman J, Tarumi YS, Zhong Y, Rangwala R, et al. (2005) Coordinate control of axon defasciculation and myelination by laminin-2 and -8. J Cell Biol 168: 655-666.
76. Tsiper MV, Yurchenco PD (2002) Laminin assembles into separate basement membrane and fibrillar matrices in Schwann cells. J Cell Sci 115: 1005-1015.
77. Li S, Harrison D, Carbonetto S, Fässler R, Smyth N, et al. (2002) Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation. J Cell Biol 157: 1279-1290.
78. McKee KK, Harrison D, Capizzi S, Yurchenco PD (2007) Role of laminin terminal globular domains in basement membrane assembly. J Biol Chem 282: 21437-21447.
79. McKee KK, Capizzi S, Yurchenco PD (2009) Scaffold-forming and adhesive contributions of synthetic laminin-binding proteins to basement membrane assembly. J Biol Chem 284: 8984-8994.